Poseida Therapeutics Inc (PSTX)
2.73
+0.02
(+0.74%)
USD |
NASDAQ |
Nov 22, 16:00
2.86
+0.13
(+4.76%)
After-Hours: 20:00
Poseida Therapeutics Profit Margin (Quarterly): 28.20% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 28.20% |
| June 30, 2024 | -120.8% |
| March 31, 2024 | -86.26% |
| December 31, 2023 | -101.4% |
| September 30, 2023 | -339.8% |
| June 30, 2023 | -137.2% |
| Date | Value |
|---|---|
| March 31, 2023 | -375.6% |
| December 31, 2022 | -331.5% |
| September 30, 2022 | 60.54% |
| June 30, 2022 | -1.59K% |
| March 31, 2022 | -4.05K% |
| December 31, 2021 | 4.70% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-4.05K%
Minimum
Mar 2022
60.54%
Maximum
Sep 2022
-586.6%
Average
-129.0%
Median
Profit Margin (Quarterly) Benchmarks
| Organogenesis Holdings Inc | 10.71% |
| MaxCyte Inc | -141.6% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -66.04% |
| Return on Assets | -21.23% |
| Return on Invested Capital | -40.32% |
| Operating Margin (Quarterly) | 27.52% |
| Return on Net Operating Assets | -106.7% |